Care and treatment

Resource
January 6, 2021
A study of the association between HIV stigma and viral suppression among a large, representative sample of PLHIV in the 21 communities participating in the HPTN 071 (PopART) trial in Zambia and South Africa.
Resource
December 7, 2020
For World AIDS Day 2020, the Ritshidze project, a community-led monitoring effort, released its first provincial State of Health report for Gauteng, South Africa, detailing key concerns which are underpinned by quantitative and qualitative data, and proposed solutions.
Resource
December 7, 2020
“Ritshidze” — meaning “Saving Our Lives” in TshiVenda — has been developed by people living with HIV and activists to hold the South African government and aid agencies accountable to improve overall HIV and TB service delivery through a community-led clinic monitoring system.
Event
November 25, 2020

PEPFAR will be co-hosting, with MINA, NDoH and SANAC, a Facebook live event on men’s health issues on Monday, 30 November 2020 from 11:00-12:30. 

Resource
November 25, 2020
A study comparing the characteristics and outcomes of adolescents living with perinatally acquired HIV (ALPH) Using data from 15 International epidemiology Databases to Evaluate AIDS in Southern Africa sites.
Resource
November 10, 2020
An impact assessment of a PEPFAR-funded salary support activity on site staffing and HIV services in Malawi.
Resource
November 9, 2020
We used screening data and routine clinic records for intervention arm patients in the Simplified Algorithm for Treatment Eligibility (SLATE) trials to describe the prevalence of tuberculosis (TB) symptoms, diagnosis and treatment among people living with HIV (PLHIV), not on antiretroviral therapy (ART) and presenting at outpatient clinics in South Africa and Kenya. We compared the performance of the WHO four-symptom TB screening tool with a baseline Xpert test.
News
November 9, 2020
The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women, was stopped early by the trial Data and Safety Monitoring Board (DSMB) as results showed CAB LA to be highly effective in preventing HIV acquisition.
Opportunity
November 5, 2020

Panagora Group's South Africa office is looking for a service provider to conduct a comprehensive salary survey for professional roles in South Africa.

Resource
November 4, 2020
An IAS conference featuring the latest in COVID-19 prevention science, policy and practice, to be held virtually on February 2, 2021.